"ll 80" Pill Images
The following drug pill images match your search criteria.
![Pill WALLACE 0640 Brown Rectangle is Tussi-12](https://www.drugs.com/images/pills/mmx/t102472f/tussi-12.jpg)
WALLACE 0640
![Pill 59911 3607 300 White Capsule/Oblong is Etodolac](https://www.drugs.com/images/pills/mmx/t101208f/etodolac.jpg)
1 / 2
Loading
59911 3607 300
![Pill I INDERAL 80 Yellow Six-sided is Inderal](https://www.drugs.com/images/pills/mmx/t103960f/inderal.jpg)
1 / 2
Loading
I INDERAL 80
![Pill WALLACE 04 30 Yellow Oval is Felbatol](https://www.drugs.com/images/pills/mmx/t100211f/felbatol.jpg)
1 / 3
Loading
WALLACE 04 30
![Pill Amneal 300 mg 1138 Blue Capsule/Oblong is Atazanavir Sulfate](https://www.drugs.com/images/pills/custom/pill30460-1/atazanavir-sulfate.jpg)
1 / 3
Loading
Amneal 300 mg 1138
Atazanavir Sulfate
- Strength
- 300 mg
- Imprint
- Amneal 300 mg 1138
- Color
- Blue / Red
- Shape
- Capsule/Oblong
![Pill GSF1L 80 mg White Capsule/Oblong is Carvedilol Phosphate Extended-Release](https://www.drugs.com/images/pills/custom/pill30633-1/carvedilol-phosphate-extended-release.jpeg)
GSF1L 80 mg
Carvedilol Phosphate Extended-Release
- Strength
- 80 mg
- Imprint
- GSF1L 80 mg
- Color
- White
- Shape
- Capsule/Oblong
![Pill Lannett 1781 180 mg Orange & White Capsule/Oblong is Temozolomide](/img/pillid/no-image-placeholder.png)
Lannett 1781 180 mg
Temozolomide
- Strength
- 180 mg
- Imprint
- Lannett 1781 180 mg
- Color
- Orange & White
- Shape
- Capsule/Oblong
![Pill 300 AXID logo Reliant Brown & Yellow Capsule/Oblong is Axid Pulvules](https://www.drugs.com/images/pills/mmx/t101007f/axid-pulvules.jpg)
1 / 2
Loading
300 AXID logo Reliant
Axid Pulvules
- Strength
- 300 mg
- Imprint
- 300 AXID logo Reliant
- Color
- Brown & Yellow
- Shape
- Capsule/Oblong
1 / 2
Loading
barr 180 mg 1160
Temozolomide
- Strength
- 180 mg
- Imprint
- barr 180 mg 1160
- Color
- Orange & White
- Shape
- Capsule/Oblong
![Pill WALLACE 04 31 Orange Oval is Felbatol](https://www.drugs.com/images/pills/mmx/t100213f/felbatol.jpg)
1 / 3
Loading
WALLACE 04 31
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.